Stockscreener 앱 받기
79.71
1.61%
1.22
전일 마감가:
$78.49
열려 있는:
$79.49
하루 거래량:
3.18M
Relative Volume:
0.72
시가총액:
$46.76B
수익:
$5.69B
순이익/손실:
$4.15B
주가수익비율:
11.47
EPS:
6.95
순현금흐름:
$623.10M
1주 성능:
+4.52%
1개월 성능:
+1.97%
6개월 성능:
+12.12%
1년 성능:
+25.12%
1일 변동 폭
$79.11
$80.06
1주일 범위
$75.39
$83.00
52주 변동 폭
$59.41
$83.00
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
79.72 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
|
ABT
Abbott Laboratories
|
127.22 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.48 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
399.77 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.31 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Edwards Lifesciences Stock (EW) Opinions on Q2 Earnings Beat - Quiver Quantitative
Edwards Lifesciences’ Pivotal Trial: A Game-Changer for Tricuspid Valve Repair? - TipRanks
Edwards Lifesciences Corporation (NYSE:EW) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts upgrade Edwards as TAVR segment improves - MassDevice
BTIG upgrades Edwards Lifesciences stock to Buy on TAVR segment stability - Investing.com
Edwards Lifesciences prevails in heart valve dispute at the UPC - JUVE Patent
Edwards Lifesciences Insider Makes a Major Stock Move! - TipRanks
Edwards Lifesciences Reports Strong Growth and Raises Guidance - TipRanks
Edwards Lifesciences debuts heart valve failure PSA as Rams training camp begins - Medical Marketing and Media
Edwards Lifesciences stock price target raised to $85 by Bernstein - Investing.com
Edwards Lifesciences stock price target raised to $85 by UBS on strong TAVR sales - Investing.com
Edwards Lifesciences’ SWOT analysis: strong TAVR growth boosts stock outlook - Investing.com
When is Edwards Lifesciences Corporation stock expected to show significant growthExceptional return forecasts - jammulinksnews.com
Is Edwards Lifesciences Corporation a growth stock or a value stockDiscover breakthrough stocks before the crowd - jammulinksnews.com
How volatile is Edwards Lifesciences Corporation stock compared to the marketFree Stock Selection - jammulinksnews.com
Edwards Lifesciences (EW) Announces Executive Leadership Change - GuruFocus
Can Edwards Lifesciences Corporation stock recover from recent declineTriple Return With Stability - metal.it
Edwards Lifesciences stock price target raised to $90 by Piper Sandler - Investing.com
Earnings Preview: What To Expect From Edwards Lifesciences' Report - MSN
Edwards Lifesciences Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
Edwards Lifesciences stock price target raised to $84 from $75 at TD Cowen - Investing.com
Edwards Lifesciences stock price target raised to $89 at RBC on growth outlook - Investing.com
JPMorgan Adjusts Edwards Lifesciences (EW) Price Target Followin - GuruFocus
Edwards Lifesciences (EW) Target Price Raised by JP Morgan | EW Stock News - GuruFocus
Edwards Lifesciences sales up nearly 12% in Q2 - MassDevice
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences Corporation Stock Analysis and ForecastPhenomenal returns - PrintWeekIndia
Edwards Lifesciences Q2 EarningsEdwards Lifesciences (NYSE:EW) - Benzinga
Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal
Edwards Lifesciences (EW) Target Price Raised by Baird Analyst | - GuruFocus
Edwards Lifesciences’ MITRIS Valve Study: A Key Development for Investors - TipRanks
Edwards Lifesciences stock reaches 52-week high at 81.86 USD - Investing.com
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results - Benzinga
Edwards Lifesciences (EW) Surpasses Earnings and Revenue Expecta - GuruFocus
Edwards Lifesciences Q2 2025 Earnings Report - MarketBeat
Edwards Lifesciences (EW) Receives Price Target Upgrade from Deutsche Bank | EW Stock News - GuruFocus
Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW) - Yahoo Finance
Edwards Lifesciences (EW) Receives Price Target Boost from Baird | EW Stock News - GuruFocus
JPMorgan Adjusts Edwards Lifesciences (EW) Price Target Following Strong Q2 Results | EW Stock News - GuruFocus
Edwards loses longtime TAVR leader Larry Wood - Yahoo Finance
Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... - Yahoo Finance
Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... By GuruFocus - Investing.com Canada
Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised Guidance - GuruFocus
Edwards Lifesciences Reports Strong Q2 Growth - TipRanks
Earnings call transcript: Edwards Lifesciences Q2 2025 beats forecasts, stock dips - Investing.com
Earnings call transcript: Edwards Lifesciences Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa
Edwards Lifesciences (EW) Surges After Earnings Report | EW Stock News - GuruFocus
After-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more - Investing.com
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
After-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more By Investing.com - Investing.com Canada
Edwards Lifesciences Corp Reports Q2 Revenue of $1.53 Billion, E - GuruFocus
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.60%
자본화:
|
볼륨(24시간):